GlassScriptPhysician profile
Christa Boss
NPI 1174854889
$5,826.61
in general payments reported to CMS, 2019-2025
37 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,642 · 2022: $1,384 · 2023: $1,736 · 2024: $1,064.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,661 · Education: $90.00 · Long Term Medical Supply Or Device Loan: $49.95.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,660.81 |
| Education | $90.00 |
| Long Term Medical Supply Or Device Loan | $49.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,181.19 | 2021-2024 | |
| Novo Nordisk INC | $606.94 | 2021-2024 | Rybelsus, Ozempic, Wegovy |
| Lilly USA, LLC | $511.26 | 2021-2024 | Mounjaro, Jardiance, Trulicity |
| Glaxosmithkline, LLC. | $311.74 | 2021-2024 | Shingrix, Arexvy, Trelegy Ellipta |
| Amgen INC. | $285.81 | 2021-2024 | Otezla, Repatha, Krystexxa |
| Abbott Laboratories | $271.87 | 2021-2024 | Freestyle Libre 3, Freestyle Insulinx |
| Takeda Pharmaceuticals U.S.A., INC. | $248.81 | 2021-2024 | Trintellix |
| Pfizer INC. | $245.96 | 2021-2024 | |
| Astrazeneca Pharmaceuticals LP | $242.90 | 2021-2024 | Airsupra, Farxiga |
| Insulet Corporation | $191.00 | 2021-2024 | Omnipod |
| Xeris Pharmaceuticals, INC. | $178.31 | 2021-2023 | Gvoke Hypopen |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $166.44 | 2021-2024 | Xifaxan, Trulance |
| Cvrx, INC. | $136.12 | 2023 | Barostim Neo System |
| Astellas Pharma US INC | $135.60 | 2023-2024 | Veozah |
| Teva Pharmaceuticals USA, INC. | $130.70 | 2021-2022 |
Show all 37 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christa Boss listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.